UNLABELLED: SURF1 gene mutations are the most common cause of Leigh syndrome (LS), a rare progressive neurodegenerative disorder of infancy, characterized by symmetric necrotizing lesions and hypervascularity in the brainstem and basal ganglia, leading to death before the age of 4 years. Most of the reported mutations create premature termination codons, whereas missense mutations are rare. The aim of the study was to characterize the natural history of LS patients carrying at least one missense mutation in the SURF1 gene. Nineteen such patients (8 own cases and 11 reported in the literature) were compared with a reference group of 20 own c.845_846delCT homozygous patients, and with other LS(SURF-) cases described in the literature. Disease onset in the studied group was delayed. Acute failure to thrive and hyperventilation episodes were rare, respiratory failure did not appear before the age of 4 years. Dystonia, motor regression and eye movement dissociation developed slowly. The number of patients who survived 7 years of life totaled 9 out of 15 (60%) in the 'missense group' and 1 out of 26 (4%) patients with mutations leading to truncated proteins. IN CONCLUSION: (i) The presence of a missense mutation in the SURF1 gene may correlate with a milder course and longer survival of Leigh patients, (ii) normal magnetic resonance imaging (MRI) findings, normal blood lactate value, and only mild decrease of cytochrome c oxidase (COX) activity are not sufficient reasons to forego SURF1 mutation analysis in differential diagnosis.
UNLABELLED: SURF1 gene mutations are the most common cause of Leigh syndrome (LS), a rare progressive neurodegenerative disorder of infancy, characterized by symmetric necrotizing lesions and hypervascularity in the brainstem and basal ganglia, leading to death before the age of 4 years. Most of the reported mutations create premature termination codons, whereas missense mutations are rare. The aim of the study was to characterize the natural history of LS patients carrying at least one missense mutation in the SURF1 gene. Nineteen such patients (8 own cases and 11 reported in the literature) were compared with a reference group of 20 own c.845_846delCT homozygous patients, and with other LS(SURF-) cases described in the literature. Disease onset in the studied group was delayed. Acute failure to thrive and hyperventilation episodes were rare, respiratory failure did not appear before the age of 4 years. Dystonia, motor regression and eye movement dissociation developed slowly. The number of patients who survived 7 years of life totaled 9 out of 15 (60%) in the 'missense group' and 1 out of 26 (4%) patients with mutations leading to truncated proteins. IN CONCLUSION: (i) The presence of a missense mutation in the SURF1 gene may correlate with a milder course and longer survival of Leigh patients, (ii) normal magnetic resonance imaging (MRI) findings, normal blood lactate value, and only mild decrease of cytochrome c oxidase (COX) activity are not sufficient reasons to forego SURF1 mutation analysis in differential diagnosis.
Authors: Samantha Swenson; Andrew Cannon; Nicholas J Harris; Nicholas G Taylor; Jennifer L Fox; Oleh Khalimonchuk Journal: J Biol Chem Date: 2016-03-03 Impact factor: 5.157
Authors: Yehani Wedatilake; Ruth M Brown; Robert McFarland; Joy Yaplito-Lee; Andrew A M Morris; Mike Champion; Phillip E Jardine; Antonia Clarke; David R Thorburn; Robert W Taylor; John M Land; Katharine Forrest; Angus Dobbie; Louise Simmons; Erlend T Aasheim; David Ketteridge; Donncha Hanrahan; Anupam Chakrapani; Garry K Brown; Shamima Rahman Journal: Orphanet J Rare Dis Date: 2013-07-05 Impact factor: 4.123
Authors: Samantha A Swenson; Courtney M Moore; Jason R Marcero; Amy E Medlock; Amit R Reddi; Oleh Khalimonchuk Journal: Cells Date: 2020-02-29 Impact factor: 6.600
Authors: Cristina Mazzaccara; Bruno Mirra; Ferdinando Barretta; Martina Caiazza; Barbara Lombardo; Olga Scudiero; Nadia Tinto; Giuseppe Limongelli; Giulia Frisso Journal: Int J Mol Sci Date: 2021-05-27 Impact factor: 6.208
Authors: Nikola Kovářová; Tomáš Mráček; Hana Nůsková; Eliška Holzerová; Marek Vrbacký; Petr Pecina; Kateřina Hejzlarová; Katarína Kľučková; Jakub Rohlena; Jiri Neuzil; Josef Houštěk Journal: PLoS One Date: 2013-08-13 Impact factor: 3.240
Authors: Nikola Kovářová; Petr Pecina; Hana Nůsková; Marek Vrbacký; Massimo Zeviani; Tomáš Mráček; Carlo Viscomi; Josef Houštěk Journal: Biochim Biophys Acta Date: 2016-01-13